Andrew Sochacki, MD

Andrew Sochacki, MD

Oncology in Nashville, TN


 (615) 936-2000

Hide Show

About Dr. Sochacki


Dr. Andrew Sochacki, MD is an oncologist in Nashville, Tennessee. He is currently licensed to practice medicine in Tennessee.

Qualifications and Experience



Hide Show

Education & Training

Vanderbilt University
Fellowship, Hematology/Oncology, 2017 - 2020

Vanderbilt University
Residency, Internal Medicine, 2014 - 2017

Michigan State University College of Human Medicine
Class of 2014

Michigan State University
Bachelor of Science, Physiology, 2010

Michigan State University
Bachelor of Science, Human Biology, 2010

█████ ████ ███
▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄▄▄ ▄▄ ▄▄▄▄▄
▄▄▄▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄
Hide Show

Medical Licenses

TN State Medical License
2016 - 2021

█████ ████ ███
▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄▄▄ ▄▄ ▄▄▄▄▄
▄▄▄▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄
Hide Show

Awards

Inductee
Alpha Omega Alpha Honor Medical Society

█████ ████ ███
▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄▄▄ ▄▄ ▄▄▄▄▄
▄▄▄▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄
Hide Show

Publications



PubMed

Mutational landscape of myelodysplastic/myeloproliferative neoplasm - unclassifiable (MDS/MPN-U).
Blood
Bose, P.,Nazha, A.,Komrokji, R. S.,Patel, K. P.,Pierce, S. A.,Al-Ali, N.,Sochacki, A.,Shaver, A.,Ma, W.,Su, X.,Daver, N. G.,DiNardo, C. D.,Garcia-Manero, G.,Loghavi, S.,Bueso-Ramos, C.,Kantarjian, H. M.,Sekeres, M. A.,Savona, M. R.,Maciejewski, J. P.,Verstovsek, S.
9/23/2018

Therapeutic approaches in myelofibrosis and myelodysplastic/myeloproliferative overlap syndromes.
OncoTargets and therapy
Sochacki, A. L., Fischer, M. A., Savona, M. R.
5/5/2016

N-3 polyunsaturated Fatty acids prevent diabetic retinopathy by inhibition of retinal vascular damage and enhanced endothelial progenitor cell reparative function.
PloS one
Tikhonenko, M., Lydic, T. A., Opreanu, M., Calzi, S. L., Bozack, S., McSorley, K. M., Sochacki, A. L., Faber, M. S., Hazra, S., Duclos, S., Guberski, D. L., Reid, G. E., Grant, M. B., Busik, J. V.
2/6/2013
30 citations

See All

Abstract

Next generation myelofibrosis risk analysis in the electronic health record.
American Society of Hematology Annual Meeting
Andrew L. Sochacki, Cosmin Adrian Bejan, Shilin Zhao, Travis Spaulding, Thomas Stricker, Yaomin Xu, Michael R. Savona
12/2018
San Diego, California

Identification of myelofibrosis from electronic health records with novel algorithms and JAKextractor.
Proceedings of the Annual Meeting of the American Association for Cancer Research
Cosmin Adrian Bejan, Andrew Sochacki, Shilin Zhao, Yaomin Xu, Michael Savona
4/2018
Chicago, Illinois

Preliminary Results from a Phase I Dose Escalation Trial of Ruxolitinib and the PI3Kδ Inhibitor TGR-1202 in Myelofibrosis.
American Society of Hematology Annual Meeting
Tamara K Moyo*, Andrew Sochacki*, Gregory D Ayers, Michael T. Byrne, Stephen A. Strickland, Sanjay R. Mohan, Jill Harrison, Lynne D Berry, Channing V Dudley, Rachel Severs, Laura Dugger, Hari P. Miskin, Amy Cavers, Peter Sportelli, Laura C Michaelis, Ruben A. Mesa, and Michael R. Savona.
12/2017
San Diego, California

█████ ████ ███
▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄▄▄ ▄▄ ▄▄▄▄▄
▄▄▄▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄